Rapid Decentralised Diagnostics

Innovative Research Tools for High-Impact and Commercial Success

Spun-out from leading UK universities, we understand your challenges.

Versatile Diagnostics for Lab, Field, and Point-of-Care applications.

Tools and Consumables designed to accelerate research.

Translational Impact Help to secure funding and attract commercial collaborations.

Designed by Researchers for Researchers

"Vidiia's Assay Accelerator and VH-Platform have enhanced the quality of our research projects and increased their commercial viability."
Dr. Averil Horton, Head of Business Development and Innovation, Brunel University

VH-Platform

Our comprehensive suite of tools for research and testing

Choose individual tools or leverage the entire VH-Platform

VH-RED:

30 second extraction – no lab equipment needed. Compatible with PCR, LAMP, RPA, and more.

VH-LyoMM:

Lyophilized, pH-independent LAMP Mastermix – delivers reliable results without the need for cold chain.

VH-6:

AI-LAMP for 30-minute testing – fast, low-cost, and flexible for Laboratory research and Point-of-Care diagnostics.

VH-App:

Digital Lab Book - Manages the entire testing process and displays the AI outputs, simplifying data analysis and improving workflows.

Ideal solutions for healthcare, veterinary, agriculture, food safety, and environmental studies

Lightning-Fast
PCR comparable sensitivity and specificity
Decentralised and accessible

Assay Accelerator

Fast-track the development and validation of innovative diagnostic assays, from concept to deployment.

Assays Accelerating : 15
Opportunities left : 85

Why partner with us?

8 key universities are already benefiting from our experience and comprehensive suite of tools for research and testing

Join Our Mission: Accelerate 100 Assays by 2029

Transform your research into real-world impact:

Fast-track your assay development with expert guidance every step of the way.

Access our Platform for streamlined validation and regulatory compliance.

Enhance funding success by generating robust, publication-ready data.

Attract commercial partnerships with proven results and increased translational impact.

What are we already working on?

Diagnostic

Design

  • Zoonosis

  • Surface testing: Human and Animal

  • Foodborne parasitic diseases

Assay

Development

  • Animal Health

  • Neglected Tropical Diseases

  • Cattle

  • Poultry

Optimisation

Validation

  • Aspergillosis

  • AMR

  • Tuberculosis

Adoption

Impact testing

  • Equine

About Us

Revolutionising Diagnostics


Born from the need for rapid, cost-effective on-site testing during the COVID-19 pandemic, Vidiia transforms research into impactful diagnostics.

Leveraging AI-powered innovation, we aim to accelerate the development of 100 assays by 2029, making portable, affordable, and reliable testing accessible to all. Explore how we’re bridging the gap between discovery and real-world application to set new standards in diagnostic innovation.

What our customers say!

"Partnering with Vidiia has significantly de-risked commercial assay development projects enabling Universities such as the University of Surrey to advance assay/technology readiness levels on reduced investment and timeframes compared to previous commercial models. Their collaborative approach, technical expertise and commercial thinking gelled perfectly with our researcher’s scientific knowledge leading to multiple market ready solutions. I’m pleased to recommend partnering with Vidiia to any academic institution looking to transfer assays from the research lab into society."​​

Dr Will Lovegrove, University of Surrey, Director of Innovation Strategy, 2020-2024

"Vidiia has been supporting Brunel to bridge the gap between our academic research and practical applications. Their team’s professionalism and innovative approach to developing assays through their accelerator and AI Diagnostics platform have not only enhanced the quality of our projects but also increased their commercial viability. Working with Vidiia has been insightful for our technology transfer department, providing the support we needed to bring our discoveries to the forefront."​

Dr Averil Horton, Brunel University Head, Business Development and Innovation.

Contact us to get a copy of our case studies

University of Surrey
Brunel University London
TB in Ghana